HOME >> BIOLOGY >> NEWS
Smallpox outbreak: How long would it take for vaccines to protect people? Would it work?

ST. LOUIS -- In the event of a smallpox outbreak in the United States, how long would it take for a vaccinSLU scientist leads national studye to start protecting Americans by stimulating an immune response?

A new national study led by Saint Louis University School of Medicine will attempt to answer this question.

General routine vaccinations for smallpox were stopped in the United States in 1971, and the world was declared free of smallpox in 1980. But because of the recent concern about biowarfare and bioterrorism throughout the world, the U.S. government is making efforts to improve its ability to protect its citizens in the event of a bioterrorist attack involving the smallpox virus (Variola major virus).

This study at Saint Louis University will look at the ability of an investigational vaccine made by Bavarian Nordic to stimulate the immune system against smallpox.

"Vaccines prevent disease by giving the body a jump-start at recognizing the infecting virus or bacteria," said Sharon Frey, M.D., the principal investigator for the study at Saint Louis University. "After successful vaccination, the body experiences a quicker fighting response to the infection, which lessens or completely avoids the symptoms of illness."

Unlike some other diseases, getting vaccinated following exposure to smallpox could provide protective effects. For example, for the flu vaccine to work, people need to get vaccinated before being exposed to influenza. The currently licensed smallpox vaccine, however, provides benefits post-exposure, and may be useful in further preventing the spread of the disease.

"If there were a release of the smallpox virus, we would vaccinate people immediately after the release," Frey said. "We'd move in and vaccinate people to prevent the spread."

Frey said this research compares the ability of a new investigational smallpox vaccine called IMVAMUNE to produce a strong immune response
'"/>

Contact: Joe Muehlenkamp
muehlenk@slu.edu
314-977-8015
Saint Louis University
30-Apr-2007


Page: 1 2

Related biology news :

1. AAAS analysis finds Congress would add billions to FY 2008 R&D investment
2. The bee that would be queen
3. 2-protein team would be lost without each other
4. Healthy coastal wetlands would adapt to rising oceans
5. Is it ethical for scientists to do research abroad that would be forbidden at home?
6. Designer babies - what would you do for a healthy baby?
7. New discovery: If it werent for this enzyme, decomposing pesticide would take millennia
8. Proposal would allow wild animals to roam North America
9. Cookbook recipes would cure disease with nontoxic DNA delivery systems
10. Passage of Marin County GMO ban would encourage widespread use of harsh pesticides
11. Passage of GMO ban in San Luis Obispo would encourage use of harsh pesticides

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/2/2020)... ... 02, 2020 , ... With the integration, the company will ... as medical grade plastic products to the world’s leading pharmaceutical, medical device, biologics, ... excited to bring even more advantages and convenience to our partners and supply ...
(Date:12/30/2019)... ... December 30, 2019 , ... It’s been quite a year ... its highest sales in 2019, having hosted a multitude of team-building events and cooking ... the company’s La Jolla-based venue, and the company has worked hard to accommodate the ...
(Date:12/18/2019)... ... 17, 2019 , ... Mitotech S.A, a Luxembourg-based clinical-stage biotechnology ... U.S. Phase 3 study VISTA-2 building on positive results of VISTA-1 clinical study ... severe Dry Eye Disease (DED). SkQ1 belongs to the class of cardiolipin peroxidation ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... January 21, 2020 , ... ... Taylor as Southern Midwest Region Industrial and Institutional (I&I) Account Manager. Darrell will ... , Darrell brings over 30 years of sales experience working across ...
(Date:1/10/2020)... ... January 09, 2020 , ... ... today announced the acquisition of Cunesoft, a move that expands the company’s portfolio ... of life sciences companies. , Based in Munich, Germany, Cunesoft provides intelligent software ...
(Date:1/7/2020)... , ... January 07, 2020 , ... ... products and services, today announced the launch of its VivopureX™ recombinant mouse antibodies ... clones, many originally obtained from rats or hamsters, which Absolute Antibody has engineered ...
(Date:1/7/2020)... ... January 06, 2020 , ... ... second cohort of emerging biosciences ventures invited to participate in the annual program. ... develop fundable business plans and a professional network. All startups will receive an ...
Breaking Biology Technology:
Cached News: